BAX

26.34

0.27% -0.07

Vorhandelsmarkt: 26.44 0.10 +0.38%

Baxter International Inc (BAX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt BAX? Forum Prognose Aktiensplit Dividendenhistorie

Schlusskurs vom Vortag:

$26.41

Offen:

$26.51

24-Stunden-Volumen:

4.36M

Relative Volume:

0.64

Marktkapitalisierung:

$13.62B

Einnahmen:

$11.32B

Nettoeinkommen (Verlust:

$-981.00M

KGV:

-13.49

EPS:

-1.9532

Netto-Cashflow:

$714.00M

1W Leistung:

-1.46%

1M Leistung:

+18.60%

6M Leistung:

+22.06%

1J Leistung:

+10.44%

1-Tages-Spanne:

$26.09

$26.67

1-Wochen-Bereich:

$25.75

$26.78

52-Wochen-Spanne:

$15.73

$30.00

Baxter International Inc Stock (BAX) Company Profile

Firmenname

Baxter International Inc

Sektor

Healthcare (1080)

Branche

Medical Instruments & Supplies (57)

Telefon

(224) 948-2000

Adresse

ONE BAXTER PARKWAY, DEERFIELD, IL

Mitarbeiter

37,500

Twitter

@baxter_intl

Nächster Verdiensttermin

2026-07-30

Neueste SEC-Einreichungen

BAX's Discussions on Twitter

Compare BAX vs ISRG, BDX, ALC, RMD, MDLN

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BAX Baxter International Inc	26.34	13.65B	11.32B	-981.00M	714.00M	-1.9532
ISRG Intuitive Surgical Inc	378.81	132.30B	11.03B	3.16B	3.22B	8.7251
BDX Becton Dickinson Co	192.00	51.11B	21.37B	1.41B	3.07B	3.9437
ALC Alcon Inc	73.63	35.25B	10.63B	819.00M	1.59B	1.6577
RMD Resmed Inc	231.52	32.95B	5.54B	1.52B	1.74B	10.37
MDLN Medline Inc	34.26	28.58B	29.14B	1.07B	1.05B	1.1956

Baxter International Inc Stock (BAX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-31	Herabstufung	Argus	Buy → Hold
2025-08-04	Herabstufung	Stifel	Buy → Hold
2025-08-01	Herabstufung	Goldman	Buy → Neutral
2025-02-26	Fortgesetzt	Goldman	Buy
2025-02-24	Hochstufung	Argus	Hold → Buy
2025-02-20	Fortgesetzt	Barclays	Overweight
2024-07-15	Herabstufung	Morgan Stanley	Equal-Weight → Underweight
2024-05-30	Eingeleitet	Goldman	Neutral
2024-05-10	Herabstufung	TD Cowen	Buy → Hold
2023-05-30	Fortgesetzt	Morgan Stanley	Equal-Weight
2023-03-29	Eingeleitet	UBS	Neutral
2023-01-06	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2023-01-05	Herabstufung	Raymond James	Outperform → Mkt Perform
2023-01-03	Herabstufung	BofA Securities	Buy → Neutral
2022-12-19	Herabstufung	JP Morgan	Overweight → Neutral
2022-12-15	Herabstufung	Deutsche Bank	Buy → Hold
2022-12-12	Herabstufung	Citigroup	Buy → Neutral
2022-10-18	Eingeleitet	Barclays	Overweight
2022-10-12	Eingeleitet	Jefferies	Hold
2022-06-24	Herabstufung	Wells Fargo	Overweight → Equal Weight
2022-04-04	Herabstufung	Goldman	Neutral → Sell
2022-03-02	Fortgesetzt	BofA Securities	Buy
2022-02-18	Bestätigt	KeyBanc Capital Markets	Overweight
2022-02-18	Bestätigt	Morgan Stanley	Overweight
2022-02-18	Bestätigt	Raymond James	Outperform
2022-02-18	Bestätigt	Stifel	Buy
2022-02-18	Bestätigt	UBS	Neutral
2022-02-18	Bestätigt	Wells Fargo	Overweight
2022-02-11	Eingeleitet	Goldman	Neutral
2022-01-07	Fortgesetzt	Citigroup	Buy
2022-01-07	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2021-09-13	Hochstufung	Cowen	Market Perform → Outperform
2021-09-03	Hochstufung	Barclays	Equal Weight → Overweight
2021-05-25	Eingeleitet	Barclays	Equal Weight
2021-01-29	Herabstufung	Piper Sandler	Overweight → Neutral
2021-01-06	Herabstufung	UBS	Buy → Neutral
2020-12-15	Herabstufung	Goldman	Buy → Neutral
2020-10-01	Hochstufung	Citigroup	Neutral → Buy
2020-09-04	Herabstufung	Argus	Buy → Hold
2020-06-24	Eingeleitet	Oppenheimer	Outperform
2020-03-19	Hochstufung	Stifel	Hold → Buy
2020-03-18	Hochstufung	KeyBanc Capital Markets	Sector Weight → Overweight
2020-03-05	Eingeleitet	Citigroup	Neutral
2020-02-13	Eingeleitet	Goldman	Buy
2020-01-02	Hochstufung	Evercore ISI	In-line → Outperform
2019-12-17	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2019-06-26	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2019-04-08	Herabstufung	Evercore ISI	Outperform → In-line
2019-01-02	Hochstufung	Citigroup	Neutral → Buy
2019-01-02	Hochstufung	Morgan Stanley	Underweight → Overweight
2018-11-02	Hochstufung	Argus	Hold → Buy
2018-10-16	Eingeleitet	Barclays	Underweight
2018-05-17	Fortgesetzt	Piper Jaffray	Overweight
2018-02-06	Bestätigt	Citigroup	Neutral
2018-01-03	Eingeleitet	Evercore ISI	Outperform
2018-01-03	Hochstufung	Raymond James	Mkt Perform → Outperform

Alle ansehen

Baxter International Inc Aktie (BAX) Neueste Nachrichten

Aug 21, 2026

Baxter International stock holds steady as new CFO joins and analyst estimates shift - Ad-hoc-news.de

Aug 21, 2026

Zacks Research Issues Negative Estimate for BAX Earnings - MarketBeat

Aug 21, 2026

Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in Baxter International Inc. $BAX - MarketBeat

Aug 21, 2026

1,435,460 Shares in Baxter International Inc. $BAX Acquired by Tocqueville Asset Management L.P. - MarketBeat

Aug 20, 2026

Edmond DE Rothschild Holding S.A. Acquires New Shares in Baxter International Inc. $BAX - MarketBeat

Aug 20, 2026

Great Lakes Advisors LLC Purchases New Holdings in Baxter International Inc. $BAX - MarketBeat

Aug 20, 2026

BlackRock Inc. Makes New $1.74 Billion Investment in Baxter International Inc. $BAX - MarketBeat

Aug 20, 2026

Aug 19, 2026

Smith+Nephew CFO joins Baxter - MassDevice

Aug 19, 2026

Baxter International Inc. stock outperforms competitors on strong trading day - MarketWatch

Aug 19, 2026

Baxter finds its replacement finance chief, reaffirms outlook - Crain's Chicago Business

Aug 19, 2026

Baxter Appoints Smith+Nephew CFO John Rogers as Chief Financial Officer - citybiz

Aug 19, 2026

Form 8K BAXTER INTERNATIONAL INC For: 19 August By Investing.com - Investing.com Canada

Aug 19, 2026

Baxter appoints John Rogers as CFO effective October 1 By Investing.com - Investing.com Nigeria

Aug 19, 2026

Baxter appoints John Rogers as CFO effective October 1 - Investing.com

Aug 19, 2026

Baxter International Names John Rogers Chief Financial Officer - marketscreener.com

Aug 19, 2026

Baxter International Names New Chief Financial Officer - TipRanks

Aug 19, 2026

Baxter appoints John Rogers as CFO; Andrew Hider interim CFO - TradingView

Aug 19, 2026

Baxter Appoints John Rogers Chief Financial Officer - Baxter

Aug 19, 2026

Baxter International Inc. Announces CFO Changes - marketscreener.com

Aug 19, 2026

Baxter International stock steadies as debt tender offer is upsized - Ad-hoc-news.de

Aug 19, 2026

Equity Investment Corp Makes New Investment in Baxter International Inc. $BAX - MarketBeat

Aug 19, 2026

Aug 18, 2026

Baxter International interim CFO Anita Zielinski puts in her papers - Medical Buyer

Aug 18, 2026

Baxter International (BAX) Amends Credit Agreement and Upsizes D - GuruFocus

Aug 18, 2026

Baxter Upsizes Debt Tender Offer to $600 Million on Strong Demand - Minichart

Aug 18, 2026

Baxter International Revises Credit Agreement and Increases Tender Offer Limit to $600 Million - Kalkine Media

Aug 18, 2026

Baxter increases debt tender offer cap to $600 million By Investing.com - Investing.com India

Aug 18, 2026

Baxter Amends Five-Year Credit Agreement, Raises Leverage Limit and Removes World Trade Borrower - TradingView

Aug 18, 2026

Baxter International Inc. Announces Early Tender Results And Upsizing Of Previously Announced Cash Tender Offers - marketscreener.com

Aug 18, 2026

symbol__ Stock Quote Price and Forecast - CNN

Aug 18, 2026

Pzena Investment Management LLC Takes $1.39 Billion Position in Baxter International Inc. $BAX - MarketBeat

Aug 18, 2026

Baxter Stock And 2 MedTech Turnaround Plays Retail Investors Are Watching - Sahm

Aug 18, 2026

Aug 17, 2026

A Look at Baxter International Inc (BAX) After 3.1% Decline -- G - GuruFocus

Aug 17, 2026

Baxter International Inc. stock underperforms Monday when compared to competitors - MarketWatch

Aug 17, 2026

Baxter International stock extends Q2 rally as guidance and peers highlight momentum - Ad-hoc-news.de

Aug 17, 2026